Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2020 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q4: 2021-02-25 Earnings Summary

EPS of -$0.16 beats by $0.04
 | Revenue of $53.28M (22.48% Y/Y) beats by $1.23M

Health Catalyst, Inc. (HACT) Q4 2020 Earnings Conference Call February 25, 2021 5:00 PM ET

Company Participants

Adam Brown - SVP, Investor Relations
Dan Burton - Chief Executive Officer
Bryan Hunt - Chief Financial Officer

Conference Call Participants

Robert Jones - Goldman Sachs
Elizabeth Anderson - Evercore
Stephanie Davis - SVB Leerink
Richard Close - Canaccord
John Ransom - Raymond James
David Grossman - Stifel
Daniel Grosslight - Citi
Glen Santangelo - Guggenheim Securities
Iris Long - Berenberg Capital

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Health Catalyst, Inc. Q4 2020 Earnings Conference Call. [Operator instructions] Please be advised that today's conference is being recorded. [Operator instructions] I would now like to hand the conference to your speaker today, Adam Brown.

Please go ahead, sir.

Adam Brown

Good afternoon, and welcome to Health Catalyst's earnings conference call for the fourth quarter of 2020 and the full-year 2020, both of which ended on December 31, 2020. My name is Adam Brown. I'm the senior vice president of investor relations and financial planning and analysis for Health Catalyst. And with me on the call is Dan Burton, our chief executive officer; and Bryan Hunt, our chief financial officer.

A complete disclosure of our results can be found in our press release issued today, as well as in our related Form 8-K furnished to the SEC, both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com. As a reminder, today's call is being recorded, and a replay will be available following the conclusion of the call.

During the call, we will make forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding trends, strategies the impact of the COVID-19 pandemic on our business and results of

Recommended For You

About HCAT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on HCAT